Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B).
AuteursHenzi BC, Putananickal N, Schmidt S, Nagy S, Rubino-Nacht D, Schaedelin S, Amthor H, Childs AM, Deconinck N, Horrocks I, Houwen-van Opstal S, Laugel V, Lobato ML, Osorio AN, Schara-Schmidt U, Spinty S, von Moers A, Lawrence F, Hafner P, Dorchies OM, Fischer D
Posterior fossa ring-enhancing lesions in the adult immunocompetent host: illustrative cases, systematic review, and proposed diagnostic algorithm.
AuteursVan Boxstael E, de Hennin A, Vigneul E, Scoppettuolo P, El Sankari S, Bocchio AP, Borrelli S, Lolli V, van Pesch V, Slootjes SM, Finet P, Rovira À, Reich DS, Maggi P
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
